Intervention1: 10-valent Pneumococcal Conjugate Vaccine (SIILPCV10

2 trials

Sponsors

Serum Institute of India Limited, Serum Institute of India Private Limited

Phase 1

A clinical trial to study the safety profile of Serum Institute of Indiaâ??s 10-valent Pneumococcal Conjugate Vaccine (SIILPCV10) in healthy Indian young adults.

Active, not recruitingCTRI/2013/09/003961

Serum Institute of India Limited

Target: 34Updated: 2021-11-24

Phase 2

A clinical trial to study the safety and effectiveness of Serum Institute of Indiaâ??s Pneumococcal Conjugate Vaccine in Healthy Indian Toddlers.

Active, not recruitingCTRI/2015/12/006456

Serum Institute of India Private Limited

Target: 112Updated: 2021-11-24